180 related articles for article (PubMed ID: 21437071)
1. Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine.
Zilliox L; Russell JW
Diabetes Metab Syndr Obes; 2010 Jan; 3():7-17. PubMed ID: 21437071
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.
Wernicke JF; Raskin J; Rosen A; Pritchett YL; D'Souza DN; Iyengar S; Knopp K; Le TK
Curr Ther Res Clin Exp; 2006 Sep; 67(5):283-304. PubMed ID: 24678103
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine in the management of diabetic peripheral neuropathic pain.
Ormseth MJ; Scholz BA; Boomershine CS
Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
[TBL] [Abstract][Full Text] [Related]
4. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
6. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
7. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.
Wright A; Luedtke KE; Vandenberg C
J Pain Res; 2010 Dec; 4():1-10. PubMed ID: 21386950
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain.
Shah I; Ahmad W; Islam M; Jan B; Ul Haq E; Mahmood J; Iqbal N; Shah M
Cureus; 2022 Sep; 14(9):e28683. PubMed ID: 36199645
[TBL] [Abstract][Full Text] [Related]
10. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
Sultan A; Gaskell H; Derry S; Moore RA
BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
Farshchian N; Alavi A; Heydarheydari S; Moradian N
Cancer Chemother Pharmacol; 2018 Nov; 82(5):787-793. PubMed ID: 30105459
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.
Brown JP; Boulay LJ
Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):291-304. PubMed ID: 24294303
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy.
Shahid W; Kumar R; Shaikh A; Kumar S; Jameel R; Fareed S
Cureus; 2019 Jul; 11(7):e5293. PubMed ID: 31579634
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of duloxetine in a mouse model of diabetic neuropathy: Role of glia suppressing mechanisms.
Tawfik MK; Helmy SA; Badran DI; Zaitone SA
Life Sci; 2018 Jul; 205():113-124. PubMed ID: 29763613
[TBL] [Abstract][Full Text] [Related]
20. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan.
Yasuda H; Hotta N; Nakao K; Kasuga M; Kashiwagi A; Kawamori R
J Diabetes Investig; 2011 Apr; 2(2):132-9. PubMed ID: 24843472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
